(Q83457870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

1 reference

F Takahashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

N Chiba

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

K Tajima

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

T Hayashida

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

T Shimada

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

M Takahashi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

H Moriyama

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

E Brachtel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

E J Edelman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

S Ramaswamy

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

S Maheswaran

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

21 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

3084-3095

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339742%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2011.24

23 January 2020

exact match

0 references

cites work

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

A stromal gene signature associated with inflammatory breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

BTG gene expression in the p53-dependent and -independent cellular response to DNA damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Molecular predictors of response to trastuzumab and lapatinib in breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Stromal gene expression predicts clinical outcome in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Targeting HER proteins in cancer therapy and the role of the non-target HER3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Gene expression predictors of breast cancer outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

The ErbB receptor tyrosine family as signal integrators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Lapatinib restores hormone sensitivity with differential effects on estrogen receptor signaling in cell models of human epidermal growth factor receptor 2-negative breast cancer with acquired endocrine resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

BTG/TOB factors impact deadenylases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

The BTG2 protein is a general activator of mRNA deadenylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Expression of B-cell translocation gene 2 protein in normal human tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Genes that mediate breast cancer metastasis to lung

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

The humoral immune system has a key prognostic impact in node-negative breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Repeated observation of breast tumor subtypes in independent gene expression data sets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Gene expression profiling predicts clinical outcome of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

A gene-expression signature as a predictor of survival in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

The mammalian anti-proliferative BTG/Tob protein family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

ErbB3-dependent motility and intravasation in breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Different gene expression patterns in invasive lobular and ductal carcinomas of the breast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24

Activated oncogenes and putative tumor suppressor genes involved in human breast cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.24